domingo, 22 de diciembre de 2019

NIAID Funding News, December 18, 2019

NIAID Logo

December 18, 2019 NIAID Funding News

Feature Articles 

Maximize Research Funds and Fill Gaps With NIAID Resources

Our Resources for Researchers page could save you time and money by fulfilling a research need, such as obtaining a reagent, using state-of-the-art analytical tools to examine datasets, or accessing preclinical services.

Opportunities and Resources

NIH's Niche Assessment Program helps active Phase I small business grantees optimize their commercialization plans by providing market insight and data to better define a target market.
Understanding the polymorphism and diversity of the nonhuman primate (NHP) major histocompatibility complex and killer cell immunoglobulin-like receptor regions will allow researchers to better design, execute, and interpret experiments.
The funding opportunity announcement (FOA) supports development or acquisition of data, materials, tools, or services that are essential to making the most timely, high quality, and cost-efficient progress in a field.

In The News

Applications with due dates on or after May 25, 2020, must use FORMS-F application forms and guidance. We anticipate the new form set will become available on February 25, 2020.
NIAID’s interim paylines for both small grant (R03) and exploratory/developmental research grant (R21) awards are set at a 28 overall impact score.
Under NIH's new definition, an individual is considered to be of disadvantaged background if he or she meets two of seven criteria listed in the latest Notice of NIH's Interest in Diversity.
The two-day seminar and optional one-day, pre-seminar workshops will focus on topics like policy and compliance, peer review, grant writing for success, pre-award and post-award issues, and animal and human subjects research.
NIH seeks public feedback on challenges, gap areas, and bottlenecks in using macaques in biomedical studies to inform the development of research and infrastructure priorities to advance research using macaques as models.
If your research includes vertebrate laboratory animals, your institution must send an annual report to NIH's Office of Laboratory Animal Welfare (OLAW) in January 2020.

Advice Corner

NIAID sends a just-in-time (JIT) email request if funding is likely. Your assigned NIAID grants management specialist tailors the JIT message to specify the administrative and eligibility information we need from you so we can continue processing your application.

Reader Questions

New Funding Opportunities

  • NOT-AI-20-013, Notice of Special Interest (NOSI): Advancing Development of Rapid Point-of-Care Hepatitis C Virus Diagnostics
  • NOT-AI-20-017, Notice of Special Interest: Development of Nucleic Acid-based Vaccines Against Seasonal and/or Pandemic Influenza
  • NOT-OD-20-048, Notice of Special Interest: Research on the Health of Women of Understudied, Underrepresented, and Underreported (U3) Populations (Admin Supp, Clinical Trial Optional)
  • NOT-OD-20-049, Notice of Special Interest: Administrative Supplements for Research on Sex/Gender Influences (Admin Supp, Clinical Trial Optional)
  • RFA-OD-20-005, Transformative Research Award for the INCLUDE (Investigation of Co-occurring Conditions across the Lifespan to Understand Down syndrome) Project (R01, Clinical Trial Not Allowed)
  • PAR-20-072, NIAID Investigator-Initiated Program Project Applications (P01, Clinical Trial Not Allowed)
  • NOT-OD-20-032, Notice of Special Interest: Administrative Supplements for Research on Sexual and Gender Minority (SGM) Populations (Admin Supp, Clinical Trial Optional)
  • NOT-OD-20-020, Notice of Special Interest: Ruth L. Kirschstein National Research Service Award (NRSA) Fellowship Awards to Support Training in Research Related to Down Syndrome as Part of the INCLUDE Project
  • NOT-OD-20-021, Notice of Special Interest: Mentored Career Development Awards to Foster the Careers of Investigators Pursuing Research Related to Down syndrome as Part of the INCLUDE Project
  • RFA-AI-19-068, Immune Tolerance Network (UM1, Clinical Trial Required)
  • Preclinical Services for HIV Therapeutics
Find other announcements at NIAID Opportunities & Announcements.
Send suggestions or comments to deaweb@niaid.nih.gov.

No hay comentarios: